| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JPEDS.2014.10.015 |
| P698 | PubMed publication ID | 25454926 |
| P2093 | author name string | Hideyuki Okano | |
| Yu Yamaguchi | |||
| Kenjiro Kosaki | |||
| Rika Kosaki | |||
| Toshiki Takenouchi | |||
| Akiko Tanikawa | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phenotype | Q104053 |
| overgrowth syndrome | Q7113674 | ||
| P304 | page(s) | 483-486 | |
| P577 | publication date | 2014-11-18 | |
| P1433 | published in | The Journal of Pediatrics | Q7743611 |
| P1476 | title | Novel overgrowth syndrome phenotype due to recurrent de novo PDGFRB mutation. | |
| P478 | volume | 166 |
| Q52624728 | A Clinical Review of Generalized Overgrowth Syndromes in the Era of Massively Parallel Sequencing. |
| Q36045072 | A Point Mutation in PDGFRB Causes Autosomal-Dominant Penttinen Syndrome |
| Q91586180 | A case of autism spectrum disorder with cleft lip and palate carrying a mutation in exon 8 of AUTS2 |
| Q64117965 | A novel PDGFRB sequence variant in a family with a mild form of primary familial brain calcification: a case report and a review of the literature |
| Q64277870 | A novel missense PTEN mutation identified in a patient with macrocephaly and developmental delay |
| Q54997377 | A patient with germ-line gain-of-function PDGFRB p.N666H mutation and marked clinical response to imatinib. |
| Q90681983 | A tyrosine kinase-activating variant Asn666Ser in PDGFRB causes a progeria-like condition in the severe end of Penttinen syndrome |
| Q53623996 | Acute myeloid leukemia-associated DNMT3A p.Arg882His mutation in a patient with Tatton-Brown-Rahman overgrowth syndrome as a constitutional mutation. |
| Q53499818 | Biallelic mutations in NALCN: Expanding the genotypic and phenotypic spectra of IHPRF1. |
| Q99239358 | Carpal tunnel syndrome in paediatric patients: A novel association with Kosaki overgrowth syndrome |
| Q42362350 | Clinical and radiological diversity in genetically confirmed primary familial brain calcification |
| Q47835809 | Co-occurrence of a novel PDGFRB variant and likely pathogenic variant in CASR in an individual with extensive intracranial calcifications and hypocalcaemia. |
| Q92680102 | Dysregulated mesenchymal PDGFR-β drives kidney fibrosis |
| Q52598186 | Expansion of the phenotype of Kosaki overgrowth syndrome. |
| Q64074394 | Functional evaluation of PDGFB-variants in idiopathic basal ganglia calcification, using patient-derived iPS cells |
| Q54798376 | Further evidence that a blepharophimosis syndrome phenotype is associated with a specific class of mutation in the ADNP gene. |
| Q55670363 | Macrothrombocytopenia and developmental delay with a de novo CDC42 mutation: Yet another locus for thrombocytopenia and developmental delay |
| Q92335524 | Molecular mechanisms underlying nuchal hump formation in dolphin cichlid, Cyrtocara moorii |
| Q91643968 | Novel ARX mutation identified in infantile spasm syndrome patient |
| Q38882182 | PDGFRB gain-of-function mutations in sporadic infantile myofibromatosis |
| Q42819833 | PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib |
| Q37461467 | PDGFRβ regulates craniofacial development through homodimers and functional heterodimers with PDGFRα |
| Q38844997 | Pathogenetic significance and possibility as a therapeutic target of platelet derived growth factor |
| Q48106116 | Pericyte degeneration causes white matter dysfunction in the mouse central nervous system. |
| Q56930830 | Primary brain calcification: an international study reporting novel variants and associated phenotypes |
| Q42797555 | STAT1 modulates tissue wasting or overgrowth downstream from PDGFRβ. |
| Q54433943 | Truncating mutation in CSNK2B and myoclonic epilepsy. |
Search more.